Literature DB >> 23479190

Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome.

Katsunori Fujii1, Hirofumi Ohashi, Maiko Suzuki, Hiromi Hatsuse, Tadashi Shiohama, Hideki Uchikawa, Toshiyuki Miyashita.   

Abstract

Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by developmental defects and tumorigenesis. The gene responsible for NBCCS is PTCH1, encoding a receptor for the secreted protein, sonic hedgehog. Recently, a Chinese family with NBCCS carrying a missense mutation in PTCH2, a close homolog of PTCH1, was reported. However, the pathological significance of missense mutations should be discussed cautiously. Here, we report a 13-year-old girl diagnosed with NBCCS based on multiple keratocystic odontogenic tumors and rib anomalies carrying a frameshift mutation in the PTCH2 gene (c.1172_1173delCT). Considering the deleterious nature of the frameshift mutation, our study further confirmed a causative role for the PTCH2 mutation in NBCCS. The absence of typical phenotypes in this case such as palmar/plantar pits, macrocephaly, falx calcification, hypertelorism and coarse face, together with previously reported cases, suggested that individuals with NBCCS carrying a PTCH2 mutation may have a milder phenotype than those with a PTCH1 mutation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23479190     DOI: 10.1007/s10689-013-9623-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  21 in total

1.  Entire PTCH1 deletion is a common event in point mutation-negative cases with nevoid basal cell carcinoma syndrome in Japan.

Authors:  K Nagao; K Fujii; K Saito; K Sugita; M Endo; T Motojima; H Hatsuse; T Miyashita
Journal:  Clin Genet       Date:  2011-02       Impact factor: 4.438

2.  Human homolog of patched, a candidate gene for the basal cell nevus syndrome.

Authors:  R L Johnson; A L Rothman; J Xie; L V Goodrich; J W Bare; J M Bonifas; A G Quinn; R M Myers; D R Cox; E H Epstein; M P Scott
Journal:  Science       Date:  1996-06-14       Impact factor: 47.728

3.  Identification of a SUFU germline mutation in a family with Gorlin syndrome.

Authors:  L Pastorino; P Ghiorzo; S Nasti; L Battistuzzi; R Cusano; C Marzocchi; M L Garrè; M Clementi; G Bianchi Scarrà
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

4.  Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32.

Authors:  I Smyth; M A Narang; T Evans; C Heimann; Y Nakamura; G Chenevix-Trench; T Pietsch; C Wicking; B J Wainwright
Journal:  Hum Mol Genet       Date:  1999-02       Impact factor: 6.150

5.  Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation.

Authors:  Chihiro Kijima; Toshiyuki Miyashita; Maiko Suzuki; Hidehiro Oka; Kiyotaka Fujii
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

6.  Heterozygous tandem duplication within the PTCH1 gene results in nevoid basal cell carcinoma syndrome.

Authors:  Rika Kosaki; Kazuaki Nagao; Kohzoh Kameyama; Maiko Suzuki; Katsunori Fujii; Toshiyuki Miyashita
Journal:  Am J Med Genet A       Date:  2012-07       Impact factor: 2.802

7.  Altered neural cell fates and medulloblastoma in mouse patched mutants.

Authors:  L V Goodrich; L Milenković; K M Higgins; M P Scott
Journal:  Science       Date:  1997-08-22       Impact factor: 47.728

8.  Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations.

Authors:  Laurence Brugières; Gaëlle Pierron; Agnès Chompret; Brigitte Bressac-de Paillerets; Federico Di Rocco; Pascale Varlet; Alain Pierre-Kahn; Olivier Caron; Jacques Grill; Olivier Delattre
Journal:  J Med Genet       Date:  2009-10-14       Impact factor: 6.318

9.  Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome.

Authors:  H Hahn; C Wicking; P G Zaphiropoulous; M R Gailani; S Shanley; A Chidambaram; I Vorechovsky; E Holmberg; A B Unden; S Gillies; K Negus; I Smyth; C Pressman; D J Leffell; B Gerrard; A M Goldstein; M Dean; R Toftgard; G Chenevix-Trench; B Wainwright; A E Bale
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

10.  High-density oligonucleotide array with sub-kilobase resolution reveals breakpoint information of submicroscopic deletions in nevoid basal cell carcinoma syndrome.

Authors:  Katsunori Fujii; Shumpei Ishikawa; Hideki Uchikawa; Daisuke Komura; Michael H Shapero; Fan Shen; Jing Hung; Hiroshi Arai; Yoko Tanaka; Kimio Sasaki; Yoichi Kohno; Masao Yamada; Keith W Jones; Hiroyuki Aburatani; Toshiyuki Miyashita
Journal:  Hum Genet       Date:  2007-08-17       Impact factor: 4.132

View more
  24 in total

Review 1.  The immunohistochemical profile of basal cell nevus syndrome-associated and sporadic odontogenic keratocysts: a systematic review and meta-analysis.

Authors:  Eleni-Marina Kalogirou; Grigorios Thermos; Vasileios Zogopoulos; Spyros Foutadakis; Ioannis Michalopoulos; Marios Agelopoulos; Konstantinos I Tosios
Journal:  Clin Oral Investig       Date:  2021-03-17       Impact factor: 3.573

Review 2.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

Review 3.  An Overview of Autosomal Dominant Tumour Syndromes with Prominent Features in the Oral and Maxillofacial Region.

Authors:  Robert A Kennedy; Selvam Thavaraj; Salvador Diaz-Cano
Journal:  Head Neck Pathol       Date:  2017-01-21

Review 4.  Multidisciplinary approach to Gorlin-Goltz syndrome: from diagnosis to surgical treatment of jawbones.

Authors:  Francesco Spadari; Federica Pulicari; Matteo Pellegrini; Andrea Scribante; Umberto Garagiola
Journal:  Maxillofac Plast Reconstr Surg       Date:  2022-07-18

5.  A guideline for the clinical management of basal cell naevus syndrome (Gorlin-Goltz syndrome).

Authors:  B J A Verkouteren; B Cosgun; M G H C Reinders; P A W K Kessler; R J Vermeulen; M Klaassens; S Lambrechts; J R van Rheenen; M van Geel; M Vreeburg; K Mosterd
Journal:  Br J Dermatol       Date:  2021-11-08       Impact factor: 11.113

6.  Nevoid basal cell carcinoma syndrome caused by splicing mutations in the PTCH1 gene.

Authors:  Chise Kato; Kentaro Fujii; Yuto Arai; Hiromi Hatsuse; Kazuaki Nagao; Yoshinaga Takayama; Kouzou Kameyama; Katsunori Fujii; Toshiyuki Miyashita
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

7.  Biallelic PTCH1 Inactivation Is a Dominant Genomic Change in Sporadic Keratocystic Odontogenic Tumors.

Authors:  Ivan J Stojanov; Inga-Marie Schaefer; Reshma S Menon; Jay Wasman; Hamza N Gokozan; Elizabeth P Garcia; Dale A Baur; Sook-Bin Woo; Lynette M Sholl
Journal:  Am J Surg Pathol       Date:  2020-04       Impact factor: 6.298

8.  PTCH2 is not a strong candidate gene for gorlin syndrome predisposition.

Authors:  Miriam J Smith; D Gareth Evans
Journal:  Fam Cancer       Date:  2021-06-25       Impact factor: 2.446

Review 9.  PTCH1 gene mutations in Keratocystic odontogenic tumors: a study of 43 Chinese patients and a systematic review.

Authors:  Yan-Yan Guo; Jian-Yun Zhang; Xue-Fen Li; Hai-Yan Luo; Feng Chen; Tie-Jun Li
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

10.  Microdeletion of 9q22.3: A patient with minimal deletion size associated with a severe phenotype.

Authors:  Adam D Ewing; Seth W Cheetham; James J McGill; Michael Sharkey; Rick Walker; Jennifer A West; Malcolm J West; Kim M Summers
Journal:  Am J Med Genet A       Date:  2021-05-07       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.